Stevenage Bioscience Catalyst is a leading location for companies to develop and commercialise cutting edge therapeutics.

Companies based at the Stevenage Campus employ over 3,500 people. The Campus is home to major organisations including GSK, the Cell and Gene Therapy Manufacturing Catapult, LifeArc and Cytiva alongside a growing cluster of start-up companies which together have raised £2.9bn in funding.

Located within the golden triangle and the academic centres of London, Cambridge and Oxford, SBC is ideally positioned for the translation and scale-up of cutting edge innovation. 

The vibrant ecosystem is based on bringing together a range of organisations throughout the innovation pipeline from start-ups to major multinationals. This has created an exciting, knowledgeable and collegiate community where interaction and collaboration are the norm.     

Organisations joining the campus must have a focus on research, products or technologies that are relevant to the therapeutics industry and protected by a strong IP portfolio.

By working directly with the major organisations on the campus and by providing shared facilities, a supportive environment has been created that delivers access to specialist scientific facilities, business support and mentoring from senior managers with the relevant scientific and commercialisation expertise.  

The facilities have been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs. Access is offered to business support, equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies.